PRED-MOXI-BROM Trademark

Trademark Overview

On Tuesday, August 11, 2020, a trademark application was filed for PRED-MOXI-BROM with the United States Patent and Trademark Office. The USPTO has given the PRED-MOXI-BROM trademark a serial number of 90106463. The federal status of this trademark filing is REGISTERED as of Tuesday, October 19, 2021. This trademark is owned by Harrow IP, LLC. The PRED-MOXI-BROM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for ophthalmological use
pred-moxi-brom

General Information

Serial Number90106463
Word MarkPRED-MOXI-BROM
Filing DateTuesday, August 11, 2020
Status700 - REGISTERED
Status DateTuesday, October 19, 2021
Registration Number6532490
Registration DateTuesday, October 19, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical compositions for ophthalmological use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 11, 2020
Primary Code005
First Use Anywhere DateMonday, August 10, 2020
First Use In Commerce DateMonday, August 10, 2020

Trademark Owner History

Party NameHarrow IP, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205
Party NameHarrow IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205

Trademark Events

Event DateEvent Description
Friday, August 14, 2020NEW APPLICATION ENTERED
Friday, September 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 12, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 12, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 12, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 12, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 12, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 4, 2020ASSIGNED TO EXAMINER
Thursday, December 17, 2020NON-FINAL ACTION WRITTEN
Thursday, December 17, 2020NON-FINAL ACTION E-MAILED
Thursday, December 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 6, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, July 6, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, September 7, 2021TEAS PETITION TO REVIVE RECEIVED
Tuesday, September 7, 2021PETITION TO REVIVE-GRANTED
Tuesday, September 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 7, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, September 14, 2021ASSIGNED TO LIE
Tuesday, September 14, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 14, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, September 15, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 19, 2021REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

brom moxi pred ophthalmological compositions pharmaceutical